Actively Recruiting
Development of Biomarkers for Monitoring Menopause in Women
Led by Fu Jen Catholic University Hospital · Updated on 2025-05-25
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.
CONDITIONS
Official Title
Development of Biomarkers for Monitoring Menopause in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biological female, age older than 20 years old.
You will not qualify if you...
- Person with cancer.
- Person with any known acute or chronic infection.
- Person with known chronic illness under follow up or treatment.
- Pregnancy, one year within delivery, under breast feeding, or three months within breast feeding.
- Under any female hormone therapy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan, 24352
Actively Recruiting
Research Team
S
Shu-Yu Liu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here